Change from originator infliximab to biosimilar does not affect 1‐year outcome in children with inflammatory bowel disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Viven Solomon, Sydney Kuzoian, Genesis Michel, Michael Brimacombe, Jeffrey S. Hyams
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	JPGN Reports
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet